Liver kinase B1/AMP-activated protein kinase-mediated regulation by gentiopicroside ameliorates P2X7 receptor-dependent alcoholic hepatosteatosis.
Xia LiYu ZhangQuan JinKai-Li XiaMin JiangBen-Wen CuiYan-Ling WuShun-Zong SongLi-Hua LianJi-Xing NanPublished in: British journal of pharmacology (2018)
Activation of LKB1/AMPK signalling by gentiopicroside was mediated by the P2X7 receptor-NLRP3 inflammasome, suggesting the therapeutic value of blocking P2X7 receptors in the treatment of alcoholic hepatosteatosis.